F-STAR THERAPEUTICS, INC. (FSTX) Financial Statements
F-STAR THERAPEUTICS, INC. (FSTX) files with the U.S. Securities and Exchange Commission under CIK 0001566373. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2021
- Revenue
- $21.17 million
- Net Income
- -$31.28 million
- Total Assets
- $123.02 million
- Net Cash from Operations
- -$27.27 million
Fiscal year ended Dec 31, 2021. Latest periodic SEC filing: Nov 10, 2022. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for FSTX in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History